학술논문
Impact of Sars‐CoV‐2 pandemic on psoriatic patients.
Document Type
Article
Author
Source
Subject
*COVID-19 pandemic
*PSORIATIC arthritis
*VACCINATION complications
*
*
Language
ISSN
1473-2130
Abstract
N (%)No 12 (80.0) 89 (85.6) 0.70 Yes, that treatment can favor vaccine adverse reaction. 3 (20.0) 7 (6.7) 0.11 Yes, that treatment can reduce vaccine effectiveness 0 (0.0) 4 (3.9) 1.00 Yes, both 0 (0.0) 4 (3.9) 1.00 Do you consider yourself a "fragile patient" who should have a priority for vaccination? Overall, 31% of patients considered themselves as "fragile patients" who needed to receive Sars-CoV-2 vaccine with a priority for their skin condition (10%), for psoriasis treatment (7.6%), for both (1.7%) and for their comorbidities (11.8%). N (%) No 73 (90.1) 28 (73.7) 0.02 Yes, that treatment can favor vaccine adverse reaction. 6 (7.4) 4 (10.5) 0.72 Yes, that treatment can reduce vaccine effectiveness 2 (2.5) 2 (5.3) 0.59 Yes, both 0 (0.0) 4 (10.5) 0.009 Do you consider yourself a "fragile patient" who should have a priority for vaccination?. [Extracted from the article]